Prevention of Mental Disorders Through Self-efficacy Interventions
Low self-efficacy is a transdiagnostic risk factor for several mental disorders. Self-efficacy refers to one's belief that one is capable of performing a behavior necessary to successfully complete a task or achieve a goal. Consistent with theoretical models and empirical findings, individuals with low self-efficacy ar
| Condition(s) | Depression Disorders, Affective Disorders, Prevention, Substance Use Disorders, Self-Efficacy |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Low self-efficacy is a transdiagnostic risk factor for several mental disorders. Self-efficacy refers to one's belief that one is capable of performing a behavior necessary to successfully complete a task or achieve a goal. Consistent with theoretical models and empirical findings, individuals with low self-efficacy are more likely to perceive challenges as uncontrollable and threatening and thus are at increased risk for developing mental disorders during sensitive periods such as young adulthood. Self-efficacy interventions have been shown to be effective in promoting health behavior change, quality of life, and treatment adherence in patients with serious illnesses, as well as motivation and performance in students and employees. However, whether targeted self-efficacy training can pros |
| Who can participate | Inclusion Criteria: 1. age 18-30 years and 2. low scores (≤24) on the German version of the General Self-Efficacy Scale (i.e., more than one standard deviation (5.4) below the mean score of 29.4 in the German norm sample; The cutoff will be raised to scores below the mean of 29.4 (≤30) if not enough participants with low self-efficacy scores of ≤24 and without 12-month mental disorders are found and this leads to serious problems regarding the recruitment phase and the timeline of the project. 3. ability to participate in the course (German language proficiency, availability during the intervention period) Exclusion Criteria: 1. 12-month anxiety, affective, or substance use disorder (excluding nicotine dependence) 2. current psychological/psychopharmacological intervention or treatment see |
| Ages | 18 Years to 30 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Health and Medical University Potsdam |
| Locations | Potsdam, Brandenburg, Germany |
| Start date | 2024-11-18 |
| NCT ID | NCT06738953 |
| Official listing | https://clinicaltrials.gov/study/NCT06738953 |